- Toxicological Review (PDF) (228 pp, 1.85 M)
- IRIS Executive Summary (PDF) (9 pp, 207 K)
- Background, History, and Other Supporting Documents (including Appendices)
Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide (2011 Interagency Science Discussion Draft)
Notice - This site contains archived material(s).
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance. Please use the contact form if you need additional assistance.
Note: After further consideration EPA has decided to undertake an additional peer review of the revised draft assessment on how the Agency responded to the SAB panel recommendations (December 2007), the exposure-response modeling of epidemiologic data, including new analyses since the 2007 external peer review, and on the adequacy, transparency, and clarity of the revised draft assessment.
U.S. EPA. Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide (2011 Interagency Science Discussion Draft). U.S. Environmental Protection Agency, Washington, DC, EPA/600/P-03/007B, 2011.
Ethylene Oxide (EtO) is a gas at room temperature used in chemical manufacturing and as a sterilizing agent for medical equipment and a fumigating agent for spices. Human exposure can occur in occupations involving contact with the gas in production facilities and in hospitals and facilities that sterilize medical equipment. EtO can also be inhaled by residents living near production or sterilizing/fumigating facilities.
|Apr 1984||EPA released the Health Assessment Document for Ethylene Oxide (External Review Draft)(EPA-600/8-84/009A).|
|Jun 1985||EPA published the Health Assessment Document for Ethylene Oxide (Final).|
|Dec 1998||EPA begins work on new assessment of carcinogenicity of EtO.|
|Mar 2006||Completion of internal EPA review of draft assessment of carcinogenicity of EtO.|
|Aug 2006||Completion of external Federal agencies review of EPA's draft assessment of carcinogenicity of EtO.|
|Sep 2006||EPA released the draft assessment for a 30-day public comment period. [Federal Register Notice September 22, 2006]|
|Oct 2006||A 30-day extension is given for the public comment period. [Federal Register Notice October 12, 2006]|
|Nov 2006||EPA released the draft EtO peer review charge and Memo to the Science Advisory Board (SAB) for their review.|
|Jan 2007||Peer review meeting of the SAB (public meeting).|
|Dec 2007||EPA's SAB issued a final report on the review of the draft assessment of EtO.|
|Jul 2011||EPA initiated Final Agency review and Interagency Science discussion (step 6 of the IRIS process) of the draft assessment of EtO.|
|Jun 2012||EPA conducted further Agency review of the revised draft.|
|Jul 2013||EPA released a revised draft assessment for additional peer review and public review and comment (step 4 of the IRIS process). [Federal Register Notice Jul 23, 2013] The interagency science discussion draft of the assessment and related comments were made available from this site.|
Following review by SAB and consideration of public comments received, the Agency will revise the draft assessment and send it back to Final Agency review and Interagency Science Discussion (step 6 of the IRIS process). Then the carcinogenicity assessment will be finalized (step 7 of the IRIS process) and placed on the IRIS database.
This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.
- (345 pp, 3 MB, about PDF)
- (22 pp, 150 KB, about PDF)
- (6 pp, 69 KB, about PDF)
- (1 pp, 19 KB, about PDF)
- (1 pp, 15 KB, about PDF)
- (5 pp, 252 KB, about PDF)
- (90 pp, 737 KB, about PDF)
If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.